Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 5, 2004, Pages 1510-1514

  Olivier, Kenneth R ^a,b   Brown, Paul D ^a   Stafford, Scott L ^a   Ansell, Stephen M ^a   Martenson Jr , James A ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Lymphoma; Parotid gland; Radiotherapy

Indexed keywords

DISEASE CONTROL; IRRADIATION; TOXICITY;

MORBIDITY; NON-HODGKIN LYMPHOMA (NHL); PAROTID GLANDS;

RADIOTHERAPY;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CONTROL; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; IRRADIATION; MALE; MORBIDITY; MUCOSA INFLAMMATION; NECK; NONHODGKIN LYMPHOMA; OTITIS; PAROTID GLAND; PRIORITY JOURNAL; PROGNOSIS; RADIATION FIELD; RETROSPECTIVE STUDY; REVIEW; SALIVARY GLAND TOXICITY; SURVIVAL; TOXICITY; XEROSTOMIA;

EID: 10044289429     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.05.066     Document Type: Article

References (20)

1. M.J. Gleeson, M.H. Bennett, R.A. Cawson Lymphomas of salivary glands Cancer 58 1986 699 704
2. A.H. Sarris, V. Papadimitrakopoulou, M.A. Dimopoulos Primary parotid lymphoma The effect of International Prognostic Index on outcome Leuk Lymphoma 26 1997 49 56
3. N.L. Harris Lymphoid proliferations of the salivary glands Am J Clin Pathol 111 Suppl. 1 1999 S94 S103
4. C. Jacobs, R.T. Hoppe Non-Hodgkin's lymphomas of head and neck extranodal sites Int J Radiat Oncol Biol Phys 11 1985 357 364
5. C. Freeman, J.W. Berg, S.J. Cutler Occurrence and prognosis of extranodal lymphomas Cancer 29 1972 252 260
6. F.L. Ampil, R.P. Misra Malignant lymphoma of the salivary gland Case reports and review of the literature Radiat Med 5 1987 20 26
7. N. Hirokawa, M. Hareyama, H. Akiba Diagnosis and treatment of malignant lymphoma of the parotid gland Jpn J Clin Oncol 28 1998 245 249
8. A. Shikhani, M. Samara, C. Allam Primary lymphoma in the salivary glands Report of five cases and review of the literature Laryngoscope 97 1987 1438 1442
9. L. Barnes, E.N. Myers, E.P. Prokopakis Primary malignant lymphoma of the parotid gland Arch Otolaryngol Head Neck Surg 124 1998 573 577
10. A. Aviles, S. Delgado, J. Huerta-Guzman Marginal zone B cell lymphoma of the parotid glands Results of a randomised trial comparing radiotherapy to combined therapy Eur J Cancer B Oral Oncol 32B 1996 420 422
11. R.B. Wilder, D. Jones, S.L. Tucker Long-term results with radiotherapy for stage I-II follicular lymphomas Int J Radiat Oncol Biol Phys 51 2001 1219 1227
12. M.P. Mac Manus, R.T. Hoppe Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University J Clin Oncol 14 1996 1282 1290
13. M.K. Gospodarowicz, R.S. Bush, T.C. Brown Prognostic factors in nodular lymphomas A multivariate analysis based on the Princess Margaret Hospital experience Int J Radiat Oncol Biol Phys 10 1984 489 497
14. L.L. Gunderson J.E. Tepper Clinical radiation oncology 2000 Churchill Livingstone New York
15. I. Takahashi, Y. Maehara, T. Koga Role of surgery in the patients with stage I and II primary gastric lymphoma Hepatogastroenterology 50 2003 877 882
16. T. Radaszkiewicz, B. Dragosics, P. Bauer Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue Factors relevant to prognosis Gastroenterology 102 1992 1628 1638
17. S.S. Kassan, T.L. Thomas, H.M. Moutsopoulos Increased risk of lymphoma in sicca syndrome Ann Intern Med 89 1978 888 892
18. E. Zucca, A. Conconi, E. Pedrinis Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue Blood 101 2003 2489 2495
19. Committee on Self-Evaluation and Testing, Commission on Radiation Therapy Set R.T. 1 Radiation biology and radiation pathology syllabus 1975 American College of Radiology Chicago
20. K.K. Fu, T.F. Pajak, A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16